Category: Covid-19

  • Trump Halts WHO Funding

    Trump Halts WHO Funding

    U.S. President Donald Trump announced that he is halting funding to the World Health Organization (WHO) during its fight against the coronavirus outbreak.

    World leaders condemned this decision.

    “It is my belief that the World Health Organization must be supported as it is absolutely critical to the world’s efforts to win the war against Covid-19,” said Antonio Guterres, secretary general of the United Nations.

    “Blaming does not help,” Heiko Maas, the German foreign minister, wrote on Twitter. “The virus knows no borders.”

    Trump accused the WHO of “severely mismanaging and covering up” the coronavirus outbreak and said the U.S. will withhold funding until it can review the organization’s actions.

    The U.S. is the WHO’s biggest donor, and halting funding will deprive the organization of about 10 percent of its budget during the crisis.

  • Colorado Temporarily Legalizes Online Marijuana Sales

    Colorado Temporarily Legalizes Online Marijuana Sales

    Bowl of cannabis

    Colorado has made the online sale of recreational marijuana legal during the coronavirus outbreak.

    Marijuana can be purchased online and picked up at the dispensary under the executive order that went into effect on March 20. Delivery is not allowed under the order, however.

    Massachusetts, Michigan, Illinois and Oregon also allow for the online purchase of recreational marijuana, but the practice is limited because while marijuana is still federally illegal, many credit card companies will not process the purchases.

    In some states, marijuana dispensaries are listed as essential businesses and are allowed to stay open during stay-at-home orders.

    Some believe that deliveries should also be allowed during the coronavirus crisis. “We need to be able to have as little contact as possible to people,” said Ben Prater, manager of Cannabis Station by Rocky Mountain High in Denver. “If people are sick or if they’re immunocompromised, they don’t need to be leaving their house during this time. So, I think that delivery is just kind of a necessity at this point.”

    The online sale of marijuana will be prohibited again once the executive order expires. Colorado emergency rules can only stay in effect for 120 days.

  • RELX Sends Relief Supplies to Customers

    RELX Sends Relief Supplies to Customers

    Courtesy: RELX

    RELX Technology announced the extension of the RELX “For You With Care” project to support its international partners during the COVID-19 crisis. RELX will initially send 78,200 masks and over 515 gallons of hand sanitizer to its global distributors, partners and store owners.

    The supplies will be sent to countries in Asia, Europe, Canada and South America. RELX will continue to follow the developments of COVID-19 globally and will send essential supplies to its partners and employees that are in need.

    “RELX is wholly committed to supporting the well-being of our employees, partners, and store owners during the COVID-19 pandemic. As a global startup, we are doing what we can to help our global community. We hope our modest donation will help them during these trying times,” said RELX founder and CEO Kate Wang.

    In late January, RELX kicked off the RELX For You With Care Project by donating RMB 1 million to the Institute of Psychology, China Academy of Science through the Shanghai Soong Ching Ling Foundation to support a training program designed to provide mental health support services.

    Courtesy: RELX
  • Opinion: Four-Month FDA Extension Not Sufficient

    Opinion: Four-Month FDA Extension Not Sufficient

    Doctor is comparing electronic vaporizer and conventional tobacc
    Photo: Vchalup | Dreamstime.com

    Consumers are staying home and spending less as COVID-19 and social distancing mandates sweep across the globe. The extreme, necessary steps to control the spread of the virus have already taken an economic toll, and there certainly will be a long-term impact on individual businesses and workers. One industry, in particular, will likely fail without swift federal action: e-cigarettes, according to Michelle Minton with the Competitive Enterprise Institute.

    Cigarettes may prove “pandemic-proof.” Since they are often sold at outlets deemed “essential” under the current lockdown, cigarettes continue to be available and big tobacco companies have so far remained financially unscathed. But the same is not true for their lower-risk competitors. Vape shops, which sell vapor products, like e-cigarettes, have not been universally recognized as essential businesses, so they have been forced to close.

    To maximize ways to fight the virus, many states have pressed pause on certain rules and regulations (leading many to wonder if they were #NeverNeeded in the first place.) For example, Vermont Governor Phil Scott signed an order lifting the state ban on home alcohol delivery. This was a pragmatic move, as Reason’s Guy Bentley aptly put it. Vermont lawmakers understand that people still want to imbibe, and at-home delivery discourages unnecessary booze runs.

    Yet that pragmatism hasn’t been extended to e-cigarettes, and Governor Scott’s online e-cigarette sales ban enacted last year remains in place. As a result, some adults now find themselves cut off from the products they rely on to stay smoke-free. Without swift federal action, they may be cut off permanently as vape shops go belly up, and many people will revert to smoking.

    The last year has already been difficult for those who sell and enjoy vapor products. Even as the evidence that e-cigarettes are relatively harmless for adults and highly effective for smoking cessation has become clearer, calls to ban or restrict e-cigarettes have only grown louder. Groups that oppose nicotine use, no matter how safe, ramped up attacks, spending millions to promote the idea that e-cigarettes are no different than cigarettes and to foment panic over the non-existent “epidemic” of youth vaping.

    Last summer, as scores of mostly young people fell ill with a mysterious lung ailment, anti-tobacco groups (with the aid of the CDC and news media) convinced people e-cigarettes were to blame, obfuscating the fact that the injuries were caused by black market THC vaping products, contaminated with vitamin E acetate (an oil that cannot be mixed into nicotine-containing e-cigarettes).

    By exploiting fear and confusion, e-cigarette opponents amassed support among the public and lawmakers for restrictions on e-cigarettes. Cities and states instituted onerous new rules, including banning all e-cigarette sales (but not traditional cigarettes), prohibiting flavored e-cigarettes, restricting sales to in-person transactions, and criminalizing possession of certain e-cigarettes.

    Some members of Congress tried to make these rules national, holding several hearings antagonistic toward vaping and considering a number of bills. Rep. Frank Pallone’s (D-NJ) bill, which bans all flavors except “tobacco,” prohibits online and mail-order sales and raises the national tobacco purchasing age limit to 21 (which it already is), passed the House. If enacted, it would make e-cigarettes less attractive, harder to get, and more expensive—leading some to label the bill a “win for cigarettes.”

    E-cigarette supporters battled threats to products they believe saved their lives. But unless federal regulators take immediate action there will be no industry left to save: By May 12, 2020 all vapor products must either submit a pre-market tobacco application (PMTA) to the Food and Drug Administration (FDA) for approval or exit the market. Filing a PMTA is an expensive and time-consuming task, which the FDA admitted would Eliminate 99 percent of the e-cigarette market. COVID-19 disruption could make that figure nearer to 100 percent.

    Last week, the FDA submitted a request to delay the PMTA deadline by four months, but even if granted, this would merely push the inevitable end of the e-cigarette industry to September 2020. The FDA should go further: Make the process, which vapor industry experts estimate takes over 1,700 hours and millions of dollars, quicker and cheaper for small companies. Although Health and Human Services Secretary Alex Azar announced plans in January to create a “streamlined” avenue for small businesses, that has yet to materialize.

    In the meantime, anti-nicotine advocates are still trying to spread misinformation, slip state-wide vaping bans around the normal legislative process, and, ludicrously, link COVID-19 deaths to e-cigarette use—for which there is zero evidence. Worse, some have even encouraged countries to reject critically needed medical equipment like ventilators if donated by Big Tobacco.

    The outbreak of COVID-19 should elevate the value of harm reduction—the idea that you can’t entirely stop people from engaging in risky behavior, but you can reduce harm by encouraging them to do so in the least risky way possible. E-cigarettes are the best way we know so far to reduce the harms related to nicotine use. They are vastly safer than smoking and more popular than most other forms of tobacco cessation. Lawmakers should do everything in their power to keep e-cigarettes a viable option for smoking cessation.

  • Scott Gottlieb Key Voice in Pandemic

    Scott Gottlieb Key Voice in Pandemic

    Scott Gottlieb

    Scott Gottlieb, former U.S. Food and Drug Administration (FDA) commissioner, has been a consistent voice from outside the Trump administration advising on the coronavirus outbreak, according to an article on MSN.

    Gottlieb has been informally advising the coronavirus task force, and he recently supplied Trump with a “roadmap,” created by him and other experts, outlining when and how the U.S. can begin returning to more normal daily activity.

    He warned the administration in January that the coronavirus would spread to the U.S. and later warned that it would become a pandemic before the World Health Organization declared it so. Despite his early warnings going unheeded, Gottlieb has not criticized the administration but has “offered sharp words for officials and states when he disagreed with their policies,” according to MSN.

    “He’s not going to shade his views and say something that people want to hear or that might make a headline,” said Mark McClellan, a former FDA commissioner who hired Gottlieb under the George W. Bush administration. “He’s just trying to be straight up about the critical things that need to be done to respond to the pandemic. It’s not about making a name for himself or saying something that is controversial or critical just for the sake of it. It’s really with this kind of constructive goal in mind. I’ve seen that the entire time we’ve worked together.”

    Vice President Mike Pence, the coronavirus task force lead, said he had “great respect” for Gottlieb, and Trump noted that he “did a great job at [the] FDA.” Pence confirmed that Gottlieb has been advising the task force.

    Others seem to take Gottlieb’s advice to heart as well—after he released the “roadmap” to the task force, the U.S. Centers for Disease Control and Prevention changed their decision on nonmedical face masks, saying the public should wear some sort of face covering when out. After Gottlieb said that the U.S. recovery would depend on states like Texas and Florida, where officials had been pushing back against lockdowns and social distancing, being more aggressive, the Florida governor issued a stay-at-home order.

  • U.S. House Subcommittee Asks FDA to Ban Vapor

    U.S. House Subcommittee Asks FDA to Ban Vapor

    Photo: Srdjan Randjelovic | Dreamstime.com

    In what turned out not to be an April Fool’s Day joke, Rep. Raja Krishnamoorthi, the Chairman of the Subcommittee on Economic and Consumer Policy, sent a letter urging the U.S. Food and Drug Administration (FDA) to use its authority to clear the market of e-cigarettes for the duration of the coronavirus pandemic and use all available tools to encourage Americans to stop smoking and vaping.

    Earlier this week, FDA asked a federal court to delay by four months its order requiring e-cigarette manufacturers to submit applications to remain on the market by May 12, 2020, according to a statement from, according to a statement for the House Committee on Oversight and Reform. 

    The Subcommittee did not oppose this request, but instead asked FDA to take the following steps for the duration of the coronavirus crisis: 

    (1)  use all available tools to encourage Americans to stop smoking combustible cigarettes and using e-cigarettes;|
    (2)  suspend all approvals of Premarket Tobacco Product Applications; and
    (3)  commit to immediately clearing the market of all e-cigarettes by prioritizing enforcement against them.

  • U.K. Vape Shops Closed; Factories, Online Sales Remain Open

    U.K. Vape Shops Closed; Factories, Online Sales Remain Open

    Credit: VPZ

    The U.K. Vaping Industry Association (UKVIA), the country’s largest trade body representing the vapor sector, has moved to reassure vapers and smokers that the industry is still very much “open for business” despite the closure of shops following the government’s lockdown.

    In addition to online retailers and manufacturing facilities operating as usual, physical store owners are focusing on ramping up their e-commerce operations via their websites, with others setting up home delivery services.

    “Vaping businesses are by nature extremely entrepreneurial and agile and a number are repurposing their business models to continue to serve their customers,” said John Dunne, a director at the UKVIA. “Specialist online retailers are also reporting significant increases in demand during the lockdown.”

    “It is critical during these highly stressful times that vapers have access to vape products to prevent them from taking the backward step and reverting to smoking. Likewise, it enables smokers looking to quit to switch to vaping.

    “The UKVIA has published a list of its retail members who provide online and home delivery services so that vapers and smokers can simply access vape devices and e-liquids during the lockdown period.”

    The UKVIA has issued a guide to coronavirus for all its members that not only provides government guidance but also highlights a range of best practice health and safety measures to implement in the workplace to ensure the wellbeing of workers and customers.

  • BAT Working on Potential Covid-19 Vaccine

    BAT Working on Potential Covid-19 Vaccine

    British American Tobacco’s (BAT) U.S. bio-tech subsidiary, Kentucky BioProcessing (KBP), is developing a potential vaccine for Covid-19 and is now in pre-clinical testing.

    BAT hopes that if testing goes well, between 1 million and 3 million doses of the vaccine could be manufactured per week beginning in June. The work is intended to be carried out on a not-for-profit basis.

    The potential vaccine uses BAT’s proprietary, fast-growing tobacco plant technology, which is potentially safer than conventional vaccine production technology because tobacco plants can’t host pathogens that cause human disease. This technology is also faster because the elements of the vaccine accumulate in tobacco plants more quickly (six weeks in tobacco plants versus several months using conventional methods). The vaccine formulation also remains stable at room temperature unlike many conventional vaccines that require refrigeration. A single dose has the potential to deliver an effective immune response.

    In 2014, KBP was one of the few companies that created an effective treatment for Ebola, ZMapp, in conjunction with Mapp BioPharmaceuticals and the U.S. Biomedical Advanced Research and Development Authority.

    KBP was recently in headlines for cloning a portion of Covid-19’s genetic sequence, leading to the development of a potential antigen. The antigen was then inserted into tobacco plants for reproduction, purified once plants were harvested, and is now undergoing pre-clinical testing.

    BAT is exploring partnerships with government agencies to bring the vaccine to clinical studies as soon as possible. “We are engaged with the U.S. Food and Drug Administration and are seeking guidance on next steps,” said David O’Reilly, director of scientific research at BAT. “We have also engaged with the U.K.’s Department for Health and Social Care and BARDA in the U.S. to offer our support and access to our research with the aim of trying to expedite the development of a vaccine for Covid-19.

    “Vaccine development is challenging and complex work, but we believe we have made a significant breakthrough with our tobacco plant technology platform and stand ready to work with governments and all stakeholders to help win the war against Covid-19. We fully align with the United Nations’ plea for a whole-of-society approach to combat global problems,” he said.

  • Vype Debuts Week-Long Virtual Music Series

    Vype Debuts Week-Long Virtual Music Series

    Credit: Acantha Lang Music

    As a growing list of music gigs are being cancelled or postponed, musicians are still eager to connect with their fans. British American Tobacco’s (BAT) Vype brand has launched a week-long, live music series from musician’s homes.

    Each performance will feature intimate conversations with up-and-coming musicians about how they find inspiration at home along with a one of a kind live music shows, according to a Vype press note. Playing songs of resilience and hope, this free musical series is designed to inspire creative ways to connect while at home. The series will take place on Tuesday, Thursday and Friday and will be streamed on Vype_worldwide Instagram page.

    “We are committed to bringing inspiration to as many of our adult consumers as we can across the globe,” says Elly Criticou, Vapour Category Director, British American Tobacco. “We are excited to continue to offer unique experiences that encourage people to find different ways to stay in touch with each other.”

    The music series will kick-off this week with New Orleans-born Acantha Lang on Tuesday 31st March at 5pm GMT; followed by composer and pianist Okiem on Thursday April 2nd at 5pm GMT and finishing the week with singer Lil Rice on Friday April 3rd at 5pm GMT.  Performances will feature a range of musical genres including blues and soul, cinematic classical and country rock.

  • U.S. FDA Asks District Court for PMTA Extension

    U.S. FDA Asks District Court for PMTA Extension

    law

    The US Food and Drug Administration (FDA) has submitted a letter to the U.S. District Court for the District of Maryland asking Judge Grimm to extend the May 12, 2020 court-ordered PMTA deadline by 120-days to September 9, 2020 “in light of the global outbreak of respiratory illness caused by a new coronavirus.”

    The FDA explained in its submission that “the global coronavirus outbreak poses unforeseen challenges and has made the May 12 deadline a public health risk to those who cannot comply with the deadline through telework.” In addition, FDA explained that telework also will complicate and delay FDA’s review of applications, according to a release by the Vapor Technology Association (VTA).

    In deciding to request a 120-day extension, the FDA noted that it had received requests from numerous trade associations and companies, including consultants involved in the PMTA process, for extensions “between 8 weeks and 180 days, with the majority of requests for 180 days.” The VTA was one of those entities that submitted a request to FDA and did so on March 20, 2020 outlining the basis and necessity for deadline extensions for large manufacturers and small manufacturers.

    At this point in time, no one can predict the length and severity of the COVID-19 commercial shutdown. The FDA explicitly recognized this point in the Second Declaration of Director the FDA’s Center for Tobacco Products (CTP) Mitch Zeller which accompanied the letter to the Court.

    In his Declaration, Zeller stated that “it is not clear at this point what the precise impact of the COVID-19 outbreak will be on the scope of FDA’s ability to complete application reviews within the 12-month period of time once applications are filed.” 

    That is precisely why VTA requested a new deadline of November 2020 (or at least 180 days from business resumption) for large manufacturers, and a new deadline of February 2021 (or at least 270 days from business resumption) for small manufacturers, according to the VTA statement. “To that end, VTA explained that ‘the question of whether these deadline changes are sufficient or ultimately realistic can and must be re-evaluated in the coming months as more information comes to light about the length and severity of the commercial shutdown due to COVID-19.’”

    In its letter to the District Court, FDA notes that the plaintiffs (American Academy of Pediatrics, et al.) will not oppose the FDA’s request, though the plaintiffs have requested the opportunity to “express their misgivings about the extension on the record.”  In order to rule, Judge Grimm still will have to have the case remanded to him by the Fourth Circuit and then he would need to make his decision on whether or not to grant the FDA’s request.  

    However, given the strong case made by the FDA, the obvious insurmountable obstacles created by the coronavirus, and the apparent lack of opposition by the plaintiffs, a ruling extending the deadline is reasonably likely though still not certain.